Alliancebernstein L.P. raised its stake in shares of EverQuote, Inc. (NASDAQ:EVER - Free Report) by 308.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 108,890 shares of the company's stock after acquiring an additional 82,200 shares during the period. Alliancebernstein L.P. owned approximately 0.31% of EverQuote worth $2,177,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in EVER. Geode Capital Management LLC increased its holdings in EverQuote by 10.4% in the 3rd quarter. Geode Capital Management LLC now owns 595,155 shares of the company's stock valued at $12,554,000 after purchasing an additional 56,114 shares during the last quarter. Counterpoint Mutual Funds LLC raised its holdings in shares of EverQuote by 74.3% in the 4th quarter. Counterpoint Mutual Funds LLC now owns 38,053 shares of the company's stock valued at $761,000 after buying an additional 16,217 shares during the period. Intech Investment Management LLC acquired a new position in EverQuote during the 4th quarter worth about $236,000. Barclays PLC boosted its holdings in EverQuote by 331.2% during the 3rd quarter. Barclays PLC now owns 50,983 shares of the company's stock valued at $1,076,000 after acquiring an additional 39,160 shares during the period. Finally, JPMorgan Chase & Co. grew its position in EverQuote by 3,022.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 385,629 shares of the company's stock valued at $8,133,000 after acquiring an additional 373,280 shares in the last quarter. 91.54% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on EVER. Canaccord Genuity Group lowered their price objective on shares of EverQuote from $35.00 to $30.00 and set a "buy" rating for the company in a research note on Monday, February 24th. JPMorgan Chase & Co. raised their price target on shares of EverQuote from $25.00 to $29.00 and gave the company an "overweight" rating in a research report on Tuesday, February 25th. Raymond James raised EverQuote from an "outperform" rating to a "strong-buy" rating and set a $35.00 price objective on the stock in a research report on Thursday, December 26th. Finally, Needham & Company LLC lifted their price target on shares of EverQuote from $30.00 to $38.00 and gave the stock a "buy" rating in a research note on Tuesday, February 25th. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $32.33.
View Our Latest Research Report on EverQuote
EverQuote Trading Down 8.5 %
NASDAQ:EVER traded down $1.94 during midday trading on Monday, hitting $20.87. 270,888 shares of the company were exchanged, compared to its average volume of 545,167. EverQuote, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $30.03. The company has a market capitalization of $745.56 million, a PE ratio of 61.38 and a beta of 0.77. The company has a fifty day simple moving average of $24.35 and a 200 day simple moving average of $20.93.
EverQuote (NASDAQ:EVER - Get Free Report) last issued its earnings results on Monday, February 24th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.15 by $0.18. The company had revenue of $147.46 million for the quarter, compared to analyst estimates of $133.83 million. EverQuote had a net margin of 3.31% and a return on equity of 13.94%. As a group, equities research analysts expect that EverQuote, Inc. will post 0.72 EPS for the current year.
Insider Buying and Selling at EverQuote
In related news, Director John L. Shields sold 2,000 shares of EverQuote stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $20.93, for a total transaction of $41,860.00. Following the completion of the sale, the director now owns 26,515 shares in the company, valued at approximately $554,958.95. This trade represents a 7.01 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Jon Ayotte sold 7,647 shares of the company's stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $25.72, for a total transaction of $196,680.84. Following the transaction, the chief accounting officer now directly owns 58,045 shares in the company, valued at $1,492,917.40. The trade was a 11.64 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 181,607 shares of company stock valued at $5,011,502. Insiders own 29.79% of the company's stock.
EverQuote Company Profile
(
Free Report)
EverQuote, Inc operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.
Recommended Stories

Before you consider EverQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EverQuote wasn't on the list.
While EverQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.